N-Boc-Sitagliptin is a pharmaceutical intermediate used in the synthesis of sitagliptin. It is a tert-butyl carbamate derivative featuring a triazolopyrazine ring and multiple fluorine substituents, designed for controlled incorporation during the manufacturing process.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 486460-23-5
2-(1,2-benzoxazol-3-yl)ethanoic acid
pharmaceutical intermediate
(+)-pinoresinol
pharmaceutical intermediate
(2S,4S)-4-Cyano-1,2-pyrrolidinedicarboxylic acid 1-(tert-butyl) 2-methyl ester
pharmaceutical intermediate
4-Bromomethyl-1,2-dihydroquinoline-2-one
pharmaceutical intermediate
tert-butyl N-[(2R)-4-oxo-4-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-1-(2,4,5-trifluorophenyl)butan-2-yl]carbamate
RHCVXZBZEKGRQP-GFCCVEGCSA-N
CC(C)(C)OC(=O)N[C@H](CC1=CC(=C(C=C1F)F)F)CC(=O)N2CCN3C(=NN=C3C(F)(F)F)C2